Atlas Trials

Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)

Clinical trial NCT01154985 · COMPLETED

Trial details

NCT number
NCT01154985
Sponsor
Mochida Pharmaceutical Company, Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Steatohepatitis
Start date
2010-06-01
Primary completion
2012-10-01
Enrollment
243

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.